AQST vs GM · rev $28.3M vs P/E 7.5, rev $91.65B
Aquestive Therapeutics Inc (AQST) versus General Motors Company (GM) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
General Motors Company (GM) is a auto manufacturers company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported GM revenue for 2026-06-30 was $91.65B. Net income was $3.93B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
AQST currently screens at market cap $493.0M. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Not investment advice. Open the AQST and GM stock pages for the full models.
Not investment advice.